Testing effectiveness (Phase 2)Study completedNCT02264613
What this trial is testing
ALRN-6924 in Patients With Advanced Solid Tumors or Lymphomas
Who this might be right for
Solid TumorLymphomaPeripheral T-Cell Lymphoma
Aileron Therapeutics, Inc. 142